Draft:Akuma Saningong

Akuma Divine Saningong (born 9 September, 1978) is a Cameroonian- German keynote speaker, author and molecular biotechnologist. He is known for his work in bridging the gap between science and personal development. Saningong was listed among the "100 Most influentilal Africans in Germany" in 2015 and 2016.

Biography
Saningong completed his undergraduate studies in Biotechnology at Darmstadt University of Applied Sciences in 2004. Later, he obtained a masters degree in Molecular Biotechnology from the Technical University of Munich (TUM) he conducted research in epigenetics.

From 2006 to 2010, Saningong pursued his Ph.D at the University of Duisburg-Essen. His thesis, titled "Functional Studies on Par14/Par17 with emphasis on chromatin, The Cell Cyle and Protein -Protein Interactions, " focused on cellular and molecular biology.

In 2007, Saningong founded Kamerun4AfrikaClub (KAC), a non-profit organization providing education and vocational training for youth in cameroon and Africa. He served as an innovation manager and head of research and development at EurA AG until 2015.

In 2020, Saningong initiated the Epi-Health innovation and Research Network to advance technology and biological research with the aim of improving health outcomes. He also led the "Afrika-Digital-Energie" initiative which received funding from the Federal Ministry for Economic Affairs and Climate Action (BMWK).

In 2021, he founded KAC-Afrika GmbH to promote research and development collaboration between African and European companies.

Saningong spoken at international conferences, including TEDx talks and World Biotechnology Congress in Berlin.

He is a member of the federation of European Biochemical Societies and a member of the German life Science Association - Verband Biologie, Biowissenschaften and Biomedizin in Deutschland.

Publications

 * "Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data". Laumen, H.; Saningong, A.D.; Heid, I.M.; Hess, J.; Herder, C.; Claussnitzer, M.; et al. Diabetes. 58 (4): 984–991. (2009).
 * "Enhanced laccase-mediated transformation of diclofenac and flufenamic acid in the presence of bisphenol A and testing of an enzymatic membrane reactor". Hahn, V.; Meister, M.; Hussy, S.; Cordes, A.; Enderle, G.; Saningong, A.; et al. AMB Express. 8 (1): 1–11.
 * "Human DNA-binding peptidyl-prolyl cis/trans isomerase Par14 is cell cycle dependently expressed and associates with chromatin in vivo". Saningong, A.D.; Bayer, P. BMC Biochemistry. 16 (1): 1–9. (2015).
 * "Enhanced laccase-mediated transformation of diclofenac and flufenamic acid in the presence of bisphenol A and testing of an enzymatic membrane reactor". Kawami, M.; Harada, R.R.; Meister, M.; Hussy, S.; Cordes, A.; Enderle, G.; et al. BioMed Central Ltd. (Location: London).
 * "Netzwerk zur Stärkung einer biobasierten Wirtschaft". Saningong, A. Biologie in unserer Zeit. 43 (1): 18–19.
 * "Functional studies on Par14/Par17 with emphasis on chromatin, the cell cycle, and protein-protein interactions" - A Saningong. Duisburg, Essen, Univ., Diss., 2010.
 * "Unravelling the function of human DNA-binding protein Par14 in the cellular nucleus". Saningong, A.D.; Bayer, P.; Mueller, J.W. FEBS Journal. 275: 101–101.
 * "Funktionelle Charakterisierung regulatorischer Adiponectin SNPs". Laumen, H.; Saningong, A.D.; Hauner, H. Diabetologie und Stoffwechsel. 2 (S 1): V46.